Lexapro en es it fr

Lexapro Brand names, Lexapro Analogs

Lexapro Brand Names Mixture

  • No information avaliable

Lexapro Chemical_Formula


Lexapro RX_link


Lexapro fda sheet

Lexapro FDA

Lexapro msds (material safety sheet)

Lexapro Synthesis Reference

No information avaliable

Lexapro Molecular Weight

324.392 g/mol

Lexapro Melting Point

No information avaliable

Lexapro H2O Solubility

No information avaliable

Lexapro State


Lexapro LogP


Lexapro Dosage Forms


Lexapro Indication

For the treatment of major depressive disorder and Generalized Anxiety Disorder (GAD).

Lexapro Pharmacology

Escitalopram is one of a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). It is used to treat the depression associated with mood disorders. It is also used on occassion in the treatment of body dysmorphic disorder and anxiety. The antidepressant, antiobsessive-compulsive, and antibulimic actions of escitalopram are presumed to be linked to its inhibition of CNS neuronal uptake of serotonin. In vitro studies show that escitalopram is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake. Escitalopram has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs. The chronic administration of escitalopram was found to downregulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder. Escitalopram does not inhibit monoamine oxidase.

Lexapro Absorption

The absolute bioavailability of citalopram is about 80% relative to an intravenous dose

Lexapro side effects and Toxicity

Signs of overdose include convulsions, coma, dizziness, hypotension, insomnia, nausea, vomiting, sinus tachycardia, somnolence, and ECG changes (including QT prolongation).

Lexapro Patient Information

Lexapro Organisms Affected

Humans and other mammals